prednisolone sodium phosphate (Redipred)
What to know about prednisolone sodium phosphate — also sold as Redipred, PredMix, Predsol: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
prednisolone sodium phosphate (brand names: Redipred, PredMix, Predsol) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. FDA approved in the United States. Systemic corticosteroid with potential for cognitive effects, mood changes, and dependency concerns at higher doses.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Low (2 points)
- Recommended maximum duration: 21 days
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | PBS listed |
| United States (FDA) | Rx only | FDA approved |
Risk Profile
Systemic corticosteroid with potential for cognitive effects, mood changes, and dependency concerns at higher doses.
How prednisolone sodium phosphate is regulated
prednisolone sodium phosphate is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
United States FDA / CDC / State WC
FDA approved for use in the United States.
Check this medication against your full medication list
Run a full risk assessment including prednisolone sodium phosphate interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.